This inventor holds 1 USPTO granted patent. Top assignee: Lupin, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Deepak Babasaheb Nale: Innovator in HIV Integrase Inhibitor Synthesis
Introduction
Deepak Babasaheb Nale is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of HIV integrase inhibitors. His work is crucial in the ongoing battle against HIV, providing new avenues for treatment.
Latest Patents
Deepak Nale holds a patent for a process for the preparation of intermediates used for the synthesis of HIV integrase inhibitors. This patent includes the synthesis of compounds such as Bictegravir, Dolutegravir, and Cabotegravir, along with their pharmaceutically acceptable salts. His innovative approach enhances the efficiency and effectiveness of these important medications.
Career Highlights
Deepak Nale is currently employed at Lupin, Inc., a leading global pharmaceutical company. His role involves research and development, focusing on creating advanced therapeutic solutions. His expertise in medicinal chemistry has positioned him as a key player in the pharmaceutical industry.
Collaborations
Throughout his career, Deepak has collaborated with talented professionals, including Harishchandra Sambhaji Jadhav and Dhananjai Shrivastava. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their field.
Conclusion
Deepak Babasaheb Nale's contributions to the synthesis of HIV integrase inhibitors highlight his importance in the pharmaceutical industry. His innovative work continues to pave the way for new treatments, making a lasting impact on public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
